Matthew E. Korenberg - 04 Jun 2026 Form 4 Insider Report for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)

Reporting relationship: Director
Issuer ticker: LFCR
Reported as of: 04 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Jun 2026, 16:46:02 UTC
Prior SEC filing: 09 Feb 2026
Next SEC filing: 16 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Courtney Schuler, Attorney-In-Fact for Matthew Korenberg

Key filing fact

Matthew E. Korenberg filed Form 4 for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) on 05 Jun 2026.

Key facts

This page summarizes Matthew E. Korenberg's Form 4 filing for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 05 Jun 2026, 16:46.

Change

Previous filing in this sequence was filed on 09 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001649903 Primary reporting owner

Korenberg Matthew E

Relationship: Director
Address: C/O LIFECORE BIOMEDICAL, INC., 3515 LYMAN BLVD., CHASKA
Signature: /s/ Courtney Schuler, Attorney-In-Fact for Matthew Korenberg
Signature date: 05 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LFCR transaction

Common Stock

Award

Transaction value
Shares: +25,907
Change %: +59%
Price
Shares after: 69,967
Date: 04 Jun 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.

Footnote F2

Vests on earlier of June 4, 2027 or the date of the annual meeting of stockholders of the Company first held in calendar year 2027 (provided such date is no less than 50 weeks from June 4, 2026).